The calling of the Grenfell Tower Inquiry has been met with severe criticism by the bereaved families and survivors of the tragic fire. Many have described it as a “seven-year delay to justice,” expressing their frustration and anger at the slow progress in holding accountable those responsible for the disaster. Individuals like Karim Khalloufi, who
0 Comments
Recent developments in Ukraine’s political landscape have seen the wartime Minister of Foreign Affairs, Dmytro Kuleba, tendering his resignation. This move was confirmed by Ukrainian Parliament Speaker Ruslan Stefanchuk, who announced that the resignation application would be considered in the upcoming plenary session meetings. Kuleba, who assumed the role of Ukraine’s foreign minister in March
0 Comments
San Francisco 49ers receiver Brandon Aiyuk recently signed a four-year, $120 million contract extension after a turbulent and public negotiation process. Aiyuk admitted that he played a role in making the negotiations difficult at times, acknowledging that there were moments when the process became challenging. Despite the ups and downs, he believes that there are
0 Comments
The Asia-Pacific markets witnessed a significant plunge on Wednesday, with Japan’s Nikkei 225 leading the losses by dropping 3.19%. This was accompanied by a 2.79% decline in the broad-based Topix index. The downfall was attributed to the sell-off in U.S. tech stocks and concerns sparked by weak U.S. economic data. Semiconductor-related stocks bore the brunt
0 Comments
Patients with inflammatory arthritis face challenges in finding effective treatments to manage their condition. A recent study conducted in Spain has shed light on the impact of biosimilar versions of etanercept and adalimumab on treatment retention for patients with inflammatory arthritis. The study compared the retention rates of patients who started either biosimilar or originator
0 Comments